Immunomedics Warns Biosimilar Chasers Over Trodelvy

Sacituzumab Biologic Brand Was Approved By FDA In April

 
• By Dean Rudge
  
Barrier
The task of proving equivalence to complex biologics is well documented in the industry • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products